Sugammadex: New pharmacological concept for antagonizing rocuronium and vecuronium;Sugammadex: Neues pharmakologisches konzept zur antagonisierung von rocuronium und vecuronium

Anaesthesist

Volumn 58, Issue 1, 2009, Pages 66-80

  Sparr, H J ^a   Booij, L H ^b   Fuchs Buder, T ^c  

^a General Hospital Dornbirn   (Austria)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c IUT de Nancy Brabois   (France)

Author keywords

Anesthesiological concepts; Antagonization; Effectivity; Residual neuromuscular block; Side effects

Indexed keywords

CISATRACURIUM; FLUCLOXACILLIN; FUSIDATE SODIUM; NEOSTIGMINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX; SUXAMETHONIUM; TOREMIFENE; VECURONIUM;

DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; NEUROMUSCULAR BLOCKING; PHARMACODYNAMICS; REVIEW; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANDROSTANOLS; ANESTHESIA; ANIMALS; CHILD; CHILD, PRESCHOOL; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 58849164750     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-008-1455-2     Document Type: Review

References (65)

1. Alvarez-Gomez 2007 Eur J Anaesthesiol 24 124
2. Amao 2007 Anesthesiology 107 A1582
3. Arain 2005 Acta Anaesthesiol Scand 49 312
4. Baillard 2005 Br J Anaesth 95 622
5. Blobner 2007 Eur J Anaesthesiol 24 124
6. Boer 2006 Br J Anaesth 96 201
7. Boer 2006 Anesthesiology 104 718
8. Boer 2006 Br J Anaesth 96 473
9. Boer 2006 Br J Anaesth 97 681
10. Boer 2007 Anesthesiology 107 239
11. Boer 2008 Can J Anaesth 55 124
12. Bom 2002 Angew Chem 114 276
13. Broek 1994 Eur J Anaesthesiol Suppl 9 128
14. Capron 2004 Anesthesiology 100 1119
15. Dahl 2007 Anesthesiology 107 A1581
16. Davis 2004 Nat Rev Drug Discov 3 1023
17. Kam 2007 Anesthesiology 107 A1580
18. Decoopman 2007 Eur J Anaesthesiol 24 110
19. Donati 2007 Can J Anaesth 54 689
20. Duvaldestin 2007 Eur J Anaesthesiol 24 123
21. Eikermann 2004 Acta Anaesthesiol Scand 48 365
22. Eikermann 2008 Br J Anaesth 101 344
23. Eleveld 2007 Anesth Analg 104 582
24. Epemolu 2003 Anesthesiology 99 632
25. Epemolu 2002 Rapid Commun Mass Spectrom 16 1946
26. Fink 2006 Anaesthesist 55 668
27. Flockton 2007 Eur J Anaesthesiol 24 123
28. Fuchs-Buder 2007 Acta Anaesthesiol Scand 51 789
29. Fuchs-Buder 2006 Anaesthesist 55 7
30. Gijsenbergh 2005 Anesthesiology 103 695
31. Gordon 2007 Eur J Anaesthesiol 24 112
32. Groudine 2007 Anesth Analg 104 555
33. Jones 2007 Anesthesiology 107 A1577
34. Kopman 2007 Anesth Analg 105 883
35. Kopman 2006 Anesthesiology 104 631
36. Kopman 2005 Acta Anaesthesiol Scand 49 316
37. Kopman 2003 Anesthesiology 99 1050
38. Lee 2007 Anesthesiology 107 A988
39. Lemmens 2007 Anesthesiology 107 A158
40. Lysakowski 2007 Acta Anaesthesiol Scand 51 848
41. Maybauer 2007 Anaesthesia 62 12
42. McDonagh 2007 Anesthesiology 107 A1583
43. Miller 2007 Anesth Analg 104 477
44. Molina 2007 Br J Anaesth 98 624
45. Naguib 2007 Anesth Analg 104 575
46. Nigrovic 2007 J Pharmacokinet Pharmacodyn 34 771
47. Paton 1967 J Physiol 191 59
48. Plaud 2007 Eur J Anaesthesiol 24 124
49. Plaud 2008 Eur J Anaesthesiol 25 9AP3
50. Proost 2000 Br J Anaesth 85 717
51. Pühringer 2007 Eur J Anaesthesiol 24 111
52. Puhringer 2002 Acta Anaesthesiol Scand 46 364
53. Puhringer 2008 Anesthesiology 109 188
54. Roy 2002 Anesthesiology 97 1082
55. Sacan 2007 Anesth Analg 104 569
56. Shields 2006 Br J Anaesth 96 36
57. Sorgenfrei 2006 Anesthesiology 104 667
58. Sparr 2002 Anaesthesist 51 929
59. Sparr 2007 Anesthesiology 106 935
60. Staals LM, Snoeck MM, Driessen JJ et al. (2008) Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth (in press)
61. Suy 2007 Anesthesiology 106 283
62. U.S. Food and Drug Administration (2008) Sugammadex - New Drug Application (NDA) 22-225: Industry presentation of Organon USA Inc. at the meeting of Anesthetic and Life Support Drugs Advisory Committee (ALSDAC) of the Food and Food Drug Administration (FDA), March 11 2008. http://www.fda.gov/ ohrms/dockets/ac/08/slides/2008-4346s1-01-Schering-Plough-corebackup.pdf
63. U.S. Food and Drug Administration (2008) Sugammadex - New Drug Application (NDA) 22-225: FDA presentation at the meeting of Anesthetic and Life Support Drugs Advisory Committee (ALSDAC) of the Food and Food Drug Administration (FDA), March 11 2008. http://www.fda.gov/ohrms/dockets/ac/08/ slides/2008-4346s1-02-FDA-corepresentation.ppt#289,1,SUGAMMADEX (SDX) Preliminary Efficacy Findings
64. Vanacker 2007 Anesth Analg 104 563
65. Viby-Mogensen 1996 Acta Anaesthesiol Scand 40 59